1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical PracticeSkin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorderRecruitingNot stated2026-09-28NCT07746583